Speakers:
Viveca Parker - Assistant United States Attorney, USDOJ
Michael Theis – Hogan Lovells
The Department of Justice is looking for many things that manufacturers are doing to enforce the laws within the healthcare industry. Some of which are: Off-label promotion, anti-kickback violations, marketing spreads, and Best Price reporting errors. In the last few years there have been over $4 Billion in settlements by manufacturers to the DOJ for these types of violations.
They are also looking at ways that payments are made from companies to purchasers that are guised as grants, educational funding, and meeting sponsorship without taking them into consideration during the submission of their Best Price as a discount/rebate. This recently was brought to light in a complaint filed January 15, 2010 against Johnson & Johnson. There are also complaints being filed due to Temporary Price Allowance Programs where purchasers are offered prices from six months prior, but not including those price discounts in the calculations thus falsely inflating the average sales price.
Another thing to remember is that if you are submitting a false Best Price and/or AMP you are also submitting false PHS pricing, as it is based off of the those two numbers. And in reverse, there is language that covers those instances where entities are using 340B discounted products but have not reported the discount, while then submitting a claim for a rebate through Medicaid or Managed Medicaid. This means that the government has received two price concessions when they were only entitled to one. In this case the entity/pharmacist, under the new regulations, will be submitting a false claim.
The take away is that due to changes, amendments, and loosened language in the false claim rules the DOJ now has more tools than ever available to go after fraud in the programs by companies or by individuals within the company. Be diligent in your compliance efforts and if you are concerned that your actions may be interpreted as fraud it is always best to be safe than sorry. The amount of money you may save in your possibly-false actions will never negate any settlement you will have to face from a complaint.
About Us
Health Care Insights - From Policy to Practice is the trusted source for news and commentary from the nation's leading Health Care Events such as Medicaid Drug Rebate Program Summit (MDRP), Medicaid Managed Care Congress (MMCC), FDA/CMS to inform Health Plans and Pharmaceutical Manufacturers on the latest developments on Medicare, Medicaid Managed Care, Government Programs, and Health Insurance Exchanges.
Topics we cover include reform, best business practices, the latest innovations, and novel payment models.
Subscribe
Blog Archive
-
▼
2010
(111)
-
▼
September
(23)
- GP Jeopardy at IIR!
- MDRP 2010 Conference - Minimizing Revenue Leakage ...
- MDRP 2010 Conference - Best Practices in Bundling ...
- MDRP 2010 Conference - New Strategies and Opportun...
- MDRP 2010 Conference - Enforcement of the Federal ...
- MDRP 2010 Conference - 340B Pricing Structure and ...
- MDRP 2010 Conference - Successful Rebate Processin...
- MDRP 2010 Conference - Government Pricing Program ...
- MDRP 2010 Conference - Navigating the Operational ...
- MDRP 2010 Conference - State Price Reporting Laws ...
- MDRP 2010 Conference - Current CMS Rebate Data, Op...
- MDRP 2010 Conference - Translating the GP Impact o...
- MDRP 2010 Conference - Translating the Impact of H...
- MDRP 2010 Conference - Reforming Medicaid: Coverin...
- MDRP 2010 Conference - Operational and System Answers
- MDRP 2010 Conference - Estimating and Operationizi...
- MDRP 2010 Conference - Operational Process for the...
- MDRP 2010 Conference - Quantifying the Impact of t...
- MDRP 2010 Conference - Continuing Challenges from ...
- MDRP 2010 Conference - AMP after HCR: Implementati...
- 8th Annual Medicare Congress Brochure Ready for Do...
- Model health care sites opening across the nation
- Are you concerned about the influx of Medicaid Man...
-
▼
September
(23)
No comments:
Post a Comment